Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
Challenging Cases of SLE Skin Disease
Description
The presentation focuses on challenging cases of skin disease in systemic lupus erythematosus (SLE), particularly finger ulcers and other skin manifestations. The speaker discusses the various etiologies for finger ulcers, including vasculopathy and vasculitis, highlighting the importance of targeting vascular supply with therapies such as vasodilators and botulinum toxin. One case involves a 39-year-old female with deep finger ulcers treated with multiple therapies, resulting in significant improvement without altering her immunosuppressive regimen. The next case centers on a 28-year-old male who developed rashes after sun exposure, including patchy alopecia and urticarial plaques, ultimately diagnosed as neutrophilic dermatosis of SLE. His flareups included angioedema, which did not respond to typical treatments but improved with a C1 esterase inhibitor, emphasizing the significance of identifying the pathogenesis of angioedema in SLE patients. The speaker concludes by discussing the different types of angioedema and the importance of tailored treatment approaches, particularly regarding bradykinin-mediated cases.
View moreConclusions
- Finger ulcers in systemic lupus erythematosus (SLE) may result from various underlying mechanisms including inflammatory, vaso-occlusive, or mixed etiologies.
- Vascular-targeted therapies can offer benefits for treating finger ulcers associated with SLE, regardless of their specific etiology.
- Botulinum toxin emerged as an effective treatment for improving outcomes in patients with severe vascular complications associated with SLE ailments.
- Neutrophilic dermatosis can occur in SLE, and while traditional treatments may fail, newer options like anafrolumab have shown to be effective.
- Recognition of the type of angioedema in SLE is crucial for effective management, distinguishing between histaminergic and bradykinin-induced types.
- Bradykinin-induced angioedema, found in autoimmune diseases like SLE, requires different treatment strategies than histaminergic angioedema.
- Management strategies for acquired angioedema include advanced therapies targeting bradykinin to provide better patient outcomes.
- Gusdorf et al ., Medicine (Baltimore), 2014